MedPath

Comparison of Transforaminal injection in patient of lumbar disc herniatio

Not Applicable
Conditions
Health Condition 1: G719- Primary disorder of muscle, unspecified
Registration Number
CTRI/2024/02/062796
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients giving written consent will be taken

Patient in the age group of 20 to 60 years.

ASA grade I & II

Low back pain more than 3 months and unilateral lower limb with radicular pain

Posterolateral lumbar disc herniation of L4/L5 or L5/S1 segment on CT and corresponding clinical symptoms and signs

Pain level on VAS =5

No symptoms of severe nerve damage include motor paralysis, muscle atrophy and cauda equine syndrome

No history of spinal surgery

Exclusion Criteria

ASA grade III to IV

Infection

Prior epidural injection in the past 3 months, such as nerve root injection and caudal injection

Spinal tumors or tuberculosis

Multi-segmental lumbar disc herniation, spinal deformity, or spinal stenosis

•Allergic to the drug used in this study

•Symptoms of severe nerve damage including motor paralysis, muscle atrophy, and caudaequina syndrome.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare pain relief with PRP Vs Triamcinolone in transforminal epidural for radicular pain due to lumbar disc herniation via VASTimepoint: Measurements of VAS and Likert score from 0 wk,1 wk,2wk, 1 month and 3 month
Secondary Outcome Measures
NameTimeMethod
To compare patients satisfaction with PRP vsTriamcinolone <br/ ><br>To compare safety & side effects of PRP vsTriamcinolone <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath